[1]孙晓岩.有创机械通气治疗COPD患者呼吸衰竭的效果观察[J].医学信息,2020,33(05):104-106.[doi:10.3969/j.issn.1006-1959.2020.05.032]
　SUN Xiao-yan.Observation on the Effect of Invasive Mechanical Ventilation on Respiratory Failure in Patients with Chronic Obstructive Pulmonary Disease[J].Medical Information,2020,33(05):104-106.[doi:10.3969/j.issn.1006-1959.2020.05.032]
点击复制

有创机械通气治疗COPD患者呼吸衰竭的效果观察()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
33卷
期数:
2020年05期
页码:
104-106
栏目:
临床研究
出版日期:
2020-03-01

文章信息/Info

Title:
Observation on the Effect of Invasive Mechanical Ventilation on Respiratory Failure in Patients with Chronic Obstructive Pulmonary Disease
文章编号:
1006-1959（2020）05-0104-03
作者:
孙晓岩
（吉林省白山市中心医院呼吸内科，吉林 白山 134300）
Author(s):
SUN Xiao-yan
(Department of Respiratory Medicine,Baishan Central Hospital,Baishan 134300,Jilin,China)
关键词:
慢性阻塞性肺疾病; 呼吸衰竭; 有创机械通气
Keywords:
Chronic obstructive pulmonary disease; Respiratory failure; Invasive mechanical ventilation
分类号:
R563.8
DOI:
10.3969/j.issn.1006-1959.2020.05.032
文献标志码:
A
摘要:
目的 研究有创机械通气治疗慢性阻塞性肺疾病患者呼吸衰竭的效果。方法 选择2018年5月~2019年5月我院收治的慢性阻塞性肺疾病（COPD）呼吸衰竭患者110例，采用随机数字表法分为观察组和对照组，各55例。观察组采用有创机械通气治疗，对照组采用无创机械通气治疗。比较两组通气时间、住院时间、感染发生率、气管切开率以及血气指标和感染发生率。结果 观察组通气时间、住院时间均高于对照组，差异有统计学意义（P＜0.05）；气管切开率高于对照组，但差异无统计学意义（P＞0.05）；治疗后两组氧分压均高于治疗前，二氧化碳分压、心率、呼吸频率均低于治疗前，差异有统计学意义（P＜0.05），但观察组与对照组比较，差异无统计学意义（P＞0.05）；观察组感染发生率高于对照组，差异有统计学意义（P＜0.05 ）。结论 有创机械通气治疗慢性阻塞性肺疾病患者呼吸衰竭效果确切，与无创机械通气治疗效果基本一致，但有创机械通气临床感染发生率较高，建议在临床机械通气治疗中优先选择无创机械通气治疗。
Abstract:
Objective To study the effect of invasive mechanical ventilation on respiratory failure in patients with chronic obstructive pulmonary disease. Methods A total of 110 patients with chronic obstructive pulmonary disease and respiratory failure treated in our hospital from May 2018 to May 2019 were selected and divided into observation group and control group by random number table method, with 55 cases in each group. The observation group was treated with invasive mechanical ventilation, and the control group was treated with noninvasive mechanical ventilation. The ventilation time, length of hospital stay, incidence of infection, tracheotomy rate, blood gas index and incidence of infection were compared between the two groups. Results The ventilation time and length of stay in the observation group were higher than those in the control group,the differences were statistically significant (P<0.05). The tracheotomy rate was higher than that in the control group, but the differences were not statistically significant (P> 0.05). The partial pressure was higher than before treatment, and the carbon dioxide partial pressure, heart rate, and respiratory rate were lower than before treatment,the differences were statistically significant (P<0.05), but there was no significant difference between the observation group and the control group (P>0.05). The incidence of infection in the observation group was higher than that in the control group,the difference was statistically significant (P<0.05).Conclusion The effect of invasive mechanical ventilation in patients with chronic obstructive pulmonary disease on respiratory failure is definite, and it is basically the same as the effect of noninvasive mechanical ventilation. However, the incidence of clinical infection in invasive mechanical ventilation is high. It is recommended to choose noninvasive mechanical ventilation in clinical mechanical ventilation treatment.

参考文献/References:

[1]李军,庞龙滨.有创与无创机械通气治疗慢阻肺合并呼吸衰竭患者的效果对比研究[J].中国实用医药,2012,7(2):56-57.[2]袁顺蓉,刘南伶,杨三春,等.有创无创序贯机械通气治疗慢性阻塞性肺疾病合并Ⅱ型呼吸衰竭的临床研究[J].西部医学,2014,26(9):1176-1178.[3]秦北宁,宋永辉,刘新颖,等.慢性阻塞性肺疾病患者呼吸衰竭有创机械通气治疗研究[J].中华医院感染学杂志,2015,24(4):849-850.[4]江伟,杜斌.慢性阻塞性肺疾病急性加重的有创机械通气策略[J].中华结核和呼吸杂志,2014,61(8):1214-1217.[5]曹莉锋,赵秋菊,徐进步,等.不同通气模式在慢性阻塞性肺疾病急性加重合并呼吸衰竭患者有创机械通气中的应用价值[J].实用心脑肺血管病杂志,2014,21(11):35-37.[6]李庆华,闫进,何振兴.有创-无创机械序贯通气法治疗重症呼吸衰竭[J].实用医药杂志,2014,32(12):1095-1096.

相似文献/References:

[1]钟雪梅,李 黎,米热班·热夏提,等.α1-抗胰蛋白酶与维吾尔族慢性阻塞性肺疾病的相关性分析[J].医学信息,2018,31(02):67.[doi:10.3969/j.issn.1006-1959.2018.02.023]
　ZHONG Xue-mei,LI Li,Mirban·rixat,et al.Correlation Analysis of α1-antitrypsin and Uygur Chronic Obstructive Pulmonary Disease[J].Medical Information,2018,31(05):67.[doi:10.3969/j.issn.1006-1959.2018.02.023]
[2]陈文福.噻托溴铵治疗稳定期慢性阻塞性肺疾病的临床疗效分析[J].医学信息,2018,31(02):124.[doi:10.3969/j.issn.1006-1959.2018.02.045]
　CHEN Wen-fu.Clinical Analysis of Tiotropium Bromide in the Treatment of Stable Chronic Obstructive Pulmonary Disease[J].Medical Information,2018,31(05):124.[doi:10.3969/j.issn.1006-1959.2018.02.045]
[3]龙有珠.氨茶碱联合呼吸功能训练治疗慢性阻塞性肺疾病的疗效分析[J].医学信息,2018,31(04):127.[doi:10.3969/j.issn.1006-1959.2018.04.045]
　LONG You-zhu.Effect of Aminophylline Combined with Respiratory Function Training on Chronic Obstructive Pulmonary Disease[J].Medical Information,2018,31(05):127.[doi:10.3969/j.issn.1006-1959.2018.04.045]
[4]皮鑫鑫,邓 革.临床药师对1例院内感染患者的病例分析[J].医学信息,2018,31(04):188.[doi:10.3969/j.issn.1006-1959.2018.04.072]
[5]罗 倩.COPD加重期患者肺功能、血气指标及 炎症指标的变化分析[J].医学信息,2018,31(09):114.[doi:10.3969/j.issn.1006-1959.2018.09.034]
　LUO Qian.Changes of Pulmonary Function,Blood Gas and Inflammation in Patients with COPD Exacerbation[J].Medical Information,2018,31(05):114.[doi:10.3969/j.issn.1006-1959.2018.09.034]
[6]赵志国.有创-无创序贯通气疗法治疗慢性阻塞性肺疾病 引发的严重呼吸衰竭的临床研究[J].医学信息,2018,31(11):110.[doi:10.3969/j.issn.1006-1959.2018.11.034]
　ZHAO Zhi-guo.Clinical Study of Invasive Non-invasive Sequential Ventilation in Treatment of Severe Respiratory Failure Caused by Chronic Obstructive Pulmonary Disease[J].Medical Information,2018,31(05):110.[doi:10.3969/j.issn.1006-1959.2018.11.034]
[7]金彦青.NPPV治疗慢性阻塞性肺疾病合并 重症呼吸衰竭的临床疗效观察[J].医学信息,2018,31(14):113.[doi:10.3969/j.issn.1006-1959.2018.14.033]
　JIN Yan-qing.Clinical Efficacy of NPPV in the Treatment of Chronic Obstructive Pulmonary Disease with Severe Respiratory Failure[J].Medical Information,2018,31(05):113.[doi:10.3969/j.issn.1006-1959.2018.14.033]
[8]何冬兰,李 文.NLR、PLR在慢性阻塞性肺疾病进展、预后中的相关研究[J].医学信息,2022,35(11):25.[doi:10.3969/j.issn.1006-1959.2022.11.008]
　HE Dong-lan,LI Wen.Study on Correlation Between NLR and PLR in the Progression and Prognosis of Chronic Obstructive Pulmonary Disease[J].Medical Information,2022,35(05):25.[doi:10.3969/j.issn.1006-1959.2022.11.008]
[9]张 林,白 俐.扶正化瘀胶囊对慢性阻塞性肺疾病患者炎性因子及 MMP-9、TIMP-1的影响[J].医学信息,2018,31(14):152.[doi:10.3969/j.issn.1006-1959.2018.14.047]
　ZHANG Lin,BAI Li.Effect of Fuzheng Huayu Capsule on Inflammatory Factors,MMP-9 and TIMP-1 in Patients with Chronic Obstructive Pulmonary Disease[J].Medical Information,2018,31(05):152.[doi:10.3969/j.issn.1006-1959.2018.14.047]
[10]张善芳,汤 杰.穴位注射联合沙美特罗替卡松粉吸入剂治疗 慢性阻塞性肺疾病稳定期的临床疗效观察[J].医学信息,2018,31(16):131.[doi:10.3969/j.issn.1006-1959.2018.16.041]
　ZHANG Shan-fang,TANG Jie.Clinical Observation of Acupoint Injection Combined with Salmeterol and Fluticasone Powder Inhalation in the Treatment of Chronic Obstructive Pulmonary Disease[J].Medical Information,2018,31(05):131.[doi:10.3969/j.issn.1006-1959.2018.16.041]
[11]吴仲东.无创机械通气用于COPD合并呼吸衰竭的疗效分析[J].医学信息,2018,31(04):106.[doi:10.3969/j.issn.1006-1959.2018.04.036]
　WU Zhong-dong.Clinical Analysis of Noninvasive Mechanical Ventilation in Patients with COPD Complicated with Respiratory Failure[J].Medical Information,2018,31(05):106.[doi:10.3969/j.issn.1006-1959.2018.04.036]
[12]夏 丽,陈 洁,李 秀.慢性阻塞性肺疾病频繁急性加重患者的临床特征分析[J].医学信息,2019,32(23):100.[doi:10.3969/j.issn.1006-1959.2019.23.027]
　XIA Li,CHEN Jie,LI Xiu.Clinical Characteristics of Patients with Chronic Exacerbation of Chronic Obstructive Pulmonary Disease[J].Medical Information,2019,32(05):100.[doi:10.3969/j.issn.1006-1959.2019.23.027]
[13]朱慧琳,胡丹平,颜金农,等.无创通气对慢性阻塞性肺疾病合并Ⅱ型呼吸衰竭患者BODE的影响[J].医学信息,2021,34(04):130.[doi:10.3969/j.issn.1006-1959.2021.04.034]
　ZHU Hui-lin,HU Dan-ping,YAN Jin-nong,et al.Effect of Non-invasive Ventilation on BODE in Patients with Chronic Obstructive Pulmonary Disease and Type Ⅱ Respiratory Failure[J].Medical Information,2021,34(05):130.[doi:10.3969/j.issn.1006-1959.2021.04.034]
[14]石婷婷,刘双全,高晓华,等.慢性阻塞性肺疾病合并社区获得性肺炎患者的临床特征及其影响因素分析[J].医学信息,2022,35(19):38.[doi:10.3969/j.issn.1006-1959.2022.19.010]
　SHI Ting-ting,LIU Shang-quan,GAO Xiao-hua,et al.Analysis of Clinical Characteristics and Influencing Factors of Patients with Chronic Obstructive Pulmonary Disease Complicated with Community-acquired Pneumonia[J].Medical Information,2022,35(05):38.[doi:10.3969/j.issn.1006-1959.2022.19.010]

更新日期/Last Update: 2020-03-01